Nicolás Saavedra Selected Research

Nicolás Saavedra Research Topics

Disease

5	Atherosclerosis 08/2022 - 09/2014
5	Neoplasms (Cancer) 01/2022 - 01/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 08/2015
4	Hypercholesterolemia 04/2022 - 02/2012
3	Atherosclerotic Plaque (Atheroma) 09/2020 - 09/2014
2	Inflammation (Inflammations) 08/2022 - 12/2020
1	COVID-19 12/2021
1	Vascular Diseases (Vascular Disease) 12/2020
1	Carcinoma (Carcinomatosis) 11/2020
1	Metaplasia 11/2020
1	Depressive Disorder (Melancholia) 08/2016
1	Coronary Disease (Coronary Heart Disease) 08/2015
1	Obesity 08/2015
1	Insulin Resistance 08/2015
1	Body Weight (Weight, Body) 08/2015
1	Abdominal Obesity 08/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2022 - 02/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2021
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2016
3	LipidsIBA 01/2021 - 02/2012
3	Propolis (Bee Bread)IBA 01/2016 - 01/2013
2	CytokinesIBA 08/2022 - 09/2020
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 08/2022 - 02/2021
2	AntioxidantsIBA 06/2022 - 01/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 05/2021
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 02/2012
2	oxidized low density lipoproteinIBA 12/2020 - 09/2020
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2020 - 09/2020
2	PolyphenolsIBA 01/2016 - 09/2014
1	fluorantheneIBA 08/2022
1	phenanthreneIBA 08/2022
1	pyreneIBA 08/2022
1	Anthocyanins (Anthocyanin)IBA 06/2022
1	drimaneIBA 12/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2020
1	SesquiterpenesIBA 12/2020
1	Ezetimibe (Zetia)FDA Link 11/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020
1	CholesterolIBA 11/2020
1	undecylprodigiosinIBA 09/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2020
1	ProdigiosinIBA 09/2020
1	Interleukin-4 (Interleukin 4)IBA 09/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Insulin (Novolin)FDA Link 08/2015
1	AdiponectinIBA 08/2015
1	IsoantibodiesIBA 01/2015
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2014
1	LDL Receptors (LDL Receptor)IBA 09/2014
1	Antiviral Agents (Antivirals)IBA 01/2013
1	Codon (Codons)IBA 01/2011

Therapy/Procedure

2	Therapeutics 08/2015 - 02/2012
1	Drug Therapy (Chemotherapy) 01/2022